Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $29 | $25 | $19 |
| Short-Term Investments | $0 | $20 | $23 | $26 |
| Receivables | $0 | $27 | $30 | $33 |
| Inventory | $26 | $25 | $25 | $26 |
| Other Curr. Assets | -$26 | $4 | $4 | $3 |
| Total Curr. Assets | $1 | $105 | $107 | $107 |
| Property Plant & Equip (Net) | $30 | $28 | $27 | $26 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $2 | $2 | $2 |
| Long-Term Investments | $1 | $86 | $108 | $92 |
| Tax Assets | $0 | $0 | $1 | $0 |
| Other NC Assets | -$30 | $23 | $0 | $22 |
| Total NC Assets | $1 | $139 | $137 | $142 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2 | $244 | $244 | $249 |
| Liabilities | – | – | – | – |
| Payables | $0 | $6 | $5 | $5 |
| Short-Term Debt | $0 | $1 | $1 | $1 |
| Tax Payable | $5 | $0 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $10 | $9 | $13 |
| Total Curr. Liab. | $0 | $18 | $17 | $20 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $16 | $0 |
| Other NC Liab. | $0 | $17 | $1 | $18 |
| Total NC Liab. | $0 | $17 | $17 | $18 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $49 | $35 | $34 | $38 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $24 | $24 | $24 |
| Retained Earnings | $1 | $129 | $131 | $128 |
| AOCI | $0 | $45 | $43 | $48 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $1 | $207 | $209 | $210 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $1 | $1 | $1 |
| Total Liab. & Tot. Equity | $261 | $244 | $244 | $249 |
| Net Debt | -$0 | -$28 | -$24 | -$17 |